Sensory and sensorimotor gating deficits after neonatal ventral hippocampal lesions in rats

Developmental Neuroscience

Volumn 34, Issue 2-3, 2012, Pages 240-249

  Swerdlow, Neal R ^a   Light, Gregory A ^a,b   Breier, Michelle R ^a   Shoemaker, Jody M ^a   Saint Marie, Richard L ^a   Neary, Alaina C ^a   Geyer, Mark A ^a,b   Stevens, Karen E ^c   Powell, Susan B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Research Education and Clinical Center (MIRECC)   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Hippocampus; Neonatal lesion; Prepulse inhibition; Schizophrenia; Sensorimotor gating; Sensory gating

Indexed keywords

IBOTENIC ACID; PROTEIN P50;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; ELECTRODE; EVENT RELATED POTENTIAL; FEMALE; HABITUATION; HIPPOCAMPUS; HISTOLOGY; MALE; NEWBORN; NONHUMAN; PERINATAL PERIOD; PHENOTYPE; PREPULSE INHIBITION; PRIORITY JOURNAL; PUBERTY; RAT; SCHIZOPHRENIA; SENSORY GATING; STARTLE REFLEX;

ACOUSTIC STIMULATION; ANIMALS; ANIMALS, NEWBORN; BRAIN INJURIES; HIPPOCAMPUS; IBOTENIC ACID; MALE; RATS; RATS, SPRAGUE-DAWLEY; SENSORY GATING; STARTLE REACTION;

EID: 84866271843     PISSN: 03785866     EISSN: 14219859     Source Type: Journal    
DOI: 10.1159/000336841     Document Type: Article

References (45)

1. Lipska BK, Jaskiw GE, Weinberger DR: Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: A potential animal model of schizophrenia. Neuropsychopharmacology 1993; 9: 67-75.
2. Tseng KY, Chambers RA, Lipska BK: The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia. Behav Brain Res 2009; 204: 295-305.
3. Lipska BK, Swerdlow NR, Geyer MA, Jaskiw GE, Braff DL, Weinberger DR: Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology 1995; 122: 35-43.
4. Graham F: The more or less startling effects of weak prestimuli. Psychophysiology 1975; 12: 238-248.
5. Braff D, Stone C, Callaway E, Geyer M, Glick I, Bali L: Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 1978; 14: 339-343.
6. Le Pen G, Moreau JL: Disruption of prepulse
7. inhibition of startle reflex in a neurodevelopmental model of schizophrenia: Reversal by clozapine, olanzapine and risperidone but not by haloperidol. Neuropsychopharmacology 2002; 27: 1-11.
8. Le Pen G, Kew J, Alberati D, Borroni E, Heitz MP, Moreau JL: Prepulse inhibition deficits of the startle reflex in neonatal ventral hippocampal- lesioned rats: Reversal by glycine and a glycine transporter inhibitor. Biol Psychiatry 2003; 54: 1162-1170.
9. Howland JG, Hannesson DK, Phillips AG: Delayed onset of prepulse inhibition deficits following kainic acid treatment on postnatal day 7 in rats. Eur J Neurosci 2004; 20: 2639- 2648.
10. Laplante F, Nakagawasai O, Srivastava LK, Quirion R: Alterations in behavioral responses to a cholinergic agonist in postpubertal rats with neonatal ventral hippocampal lesions: Relationship to changes in muscarinic receptor levels. Neuropsychopharmacology 2005; 30: 1076-1087.
11. Angst MJ, Macedo CE, Guiberteau T, Sandner G: Alteration of conditioned emotional response and conditioned taste aversion after neonatal ventral hippocampus lesions in rats. Brain Res 2007; 1143: 183-192.
12. Daenen EW, Wolterink G, Van Der Heyden JA, Kruse CG, Van Ree JM: Neonatal lesions in the amygdala or ventral hippocampus disrupt prepulse inhibition of the acoustic startle response; implications for an animal model of neurodevelopmental disorders like schizophrenia. Eur Neuropsychopharmacol 2003; 13: 187-197.
13. Swerdlow NR, Lipska BK, Weinberger DR, Braff DL, Jaskiw GE, Geyer MA: Increased sensitivity to the sensorimotor gating-disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rats. Psychopharmacology 1995; 122: 27-34.
14. Marquis JP, Goulet S, Doré FY: Neonatal lesions of the ventral hippocampus in rats lead to prefrontal cognitive deficits at two maturational stages. Neuroscience 2006; 140: 759- 767.
15. Marquis JP, Goulet S, Doré FY: Neonatal ventral hippocampus lesions disrupt extradimensional shift and alter dendritic spine density in the medial prefrontal cortex of juvenile rats. Neurobiol Learn Mem 2008; 90: 339-346.
16. Adler LE, Pachtman E, Franks RD, Pecevich M, Waldo MC, Freedman R: Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry 1982; 17: 639- 654.
17. Freedman R, Adler LE, Waldo MC, Pachtman E, Franks RD: Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: Comparison of medicated and drug-free patients. Biol Psychiatry 1983; 18: 537-551.
18. Boutros NN, Zouridakis G, Overall J: Replication and extension of P50 findings in schizophrenia. Clin Electroencephalogr 1991; 22: 40-45.
19. Adler LE, Rose G, Freedman R: Neurophysiological studies of sensory gating in rats: Effects of amphetamine, phencyclidine, and haloperidol. Biol Psychiatry 1986; 21: 787- 798.
20. Bickford-Wimer PC, Nagamoto H, Johnson R, Adler LE, Egan M, Rose GM, Freedman R: Auditory sensory gating in hippocampal neurons: A model system in the rat. Biol Psychiatry 1990; 27: 183-192.
21. Boutros NN, Uretsky N, Berntson G, Bornstein R: Effects of cocaine on sensory inhibition in rats: Preliminary data. Biol Psychiatry 1994; 36: 242-248.
22. Salamy A, Salfi M, Fein G: Sensory gating deficit following cocaine exposure in the rat. Neuropsychobiology 1997; 36: 83-86.
23. Stevens KE, Fuller LL, Rose GM: Dopaminergic and noradrenergic modulation of amphetamine- induced changes in auditory gating. Brain Res 1991; 555: 91-98.
24. Stevens KE, Meltzer J, Rose GM: Nicotinic cholinergic normalization of amphetamineinduced loss of auditory gating in freely moving rats. Psychopharmacology 1995; 119: 163-170.
25. Stevens KE, Luthman J, Lindqvist E, Johnson RG, Rose GM: Effects of neonatal dopamine depletion on sensory inhibition in the rat. Pharmacol Biochem Behav 1996; 53: 817- 823.
26. Stevens KE, Nagamoto H, Johnson RG, Adams CE, Rose GM: Kainic acid lesions in adult rats as a model of schizophrenia: Changes in auditory information processing. Neuroscience 1997; 82: 701-708.
27. Swerdlow NR, Geyer MA, Shoemaker JM, Light GA, Braff DL, Stevens KE, Sharp R, Breier M, Neary A, Auerbach PP: Convergence and divergence in the neurochemical regulation of prepulse inhibition of startle and N40 suppression in rats. Neuropsychopharmacology 2006; 31: 506-515.
28. Miller CL, Freedman R: The activity of hippocampal interneurons and pyramidal cells during the response of the hippocampus to repeated auditory stimuli. Neuroscience 1995; 69: 371-381.
29. Metzger KL, Maxwell CR, Liang Y, Siegel SJ: Effects of nicotine vary across two auditory evoked potentials in the mouse. Biol Psychiatry 2007; 61: 23-30.
30. de Bruin NM, Ellenbroek BA, Cools AR, Coenen AM, van Luijtelaar EL: Differential effects of ketamine on gating of auditory evoked potentials and prepulse inhibition in rats. Psychopharmacology 1999; 142: 9-17.
31. Ellenbroek BA, van Luijtelaar G, Frenken M, Cools AR: Sensory gating in rats: Lack of correlation between auditory evoked potential gating and prepulse inhibition. Schizophr Bull 1999; 25: 777-788.
32. Halene TB, Siegel SJ: Antipsychotic-like properties of phosphodiesterase 4 inhibitors: Evaluation of 4-(3-butoxy-4-methoxybenzyl)- 2-imidazolidinone (RO-20-1724) with auditory event-related potentials and prepulse inhibition of startle. J Pharmacol Exp Ther 2008; 326: 230-239.
33. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates, ed 4. San Diego, Academic Press, 1998.
34. CadenHead KS, Light GA, Shafer KM, Braff DL: P50 suppression in individuals at risk for schizophrenia: The convergence of clinical, familial, and vulnerability marker risk assessment. Biol Psychiatry 2005; 57: 1504- 1509.
35. Quednow BB, Frommann I, Berning J, Maier KU, Wagner M: Impaired sensorimotor gating of the acoustic startle response in the prodrome of schizophrenia. Biol Psychiatry 2008; 64: 766-773.
36. CadenHead KS: Startle reactivity and prepulse inhibition in prodromal and early psychosis: Effects of age, antipsychotics, tobacco and cannabis in a vulnerable population. Psychiatry Res 2011; 188: 208-216.
37. Vohs JL, Chambers RA, Krishnan GP, O'Donnell BF, Hetrick WP, Kaiser ST, Berg S, Morzorati SL: Auditory sensory gating in the neonatal ventral hippocampal lesion model of schizophrenia. Neuropsychobiology 2009; 60: 12-22.
38. Braff DL, Light GA, Swerdlow NR: Prepulse inhibition and P50 suppression are both deficient but not correlated in schizophrenia patients. Biol Psychiatry 2007; 61: 1204-1207.
39. Schwarzkopf SB, Lamberti JS, Smith DA: Concurrent assessment of acoustic startle and auditory P50 evoked potential measures of sensory inhibition. Biol Psychiatry 1993; 33: 815-828.
40. Oranje B, van Berckel BN, Kemmer C, van Ree JM, Kahn RS, Verbaten MN: P50 suppression and prepulse inhibition of the startle reflex in humans: A correlational study. Biol Psychiatry 1999; 45: 883-890.
41. Light GA, Braff DL: Measuring P50 suppression and prepulse inhibition in a single recording session. Am J Psychiatry 2001; 158: 2066-2068.
42. Brenner CA, Edwards CR, Carroll CA, Kieffaber PD, Hetrick WP: P50 and acoustic startle gating are not related in healthy participants. Psychophysiology 2004; 41: 702-708.
43. Rueter LE, Ballard ME, Gallagher KB, Basso AM, Curzon P, Kohlhaas KL: Chronic low dose risperidone and clozapine alleviate positive but not negative symptoms in the rat neonatal ventral hippocampal lesion model of schizophrenia. Psychopharmacology 2004; 176: 312-319.
44. Kamath A, Al-Khairi I, Bhardwaj S, Srivastava LK: Enhanced alpha-1 adrenergic sensitivity in sensorimotor gating deficits in neonatal ventral hippocampus-lesioned rats. Int J Neuropsychopharmacol 2008; 6: 1-12.
45. Ziermans TB, Schothorst PF, Sprong M, Magnée MJ, van Engeland H, Kemner C: Reduced prepulse inhibition as an early vulnerability marker of the psychosis prodrome in adolescence. Schizophr Res 2012; 134: 10-15.